The Gx Elite vials are type I vials that meet high standards. Made from borosilicate glass, the vials prevent any glass-to-glass and glass-to-metal contact. The chemical composition of the borosilicate glass is still the same. Gerresheimer will be showcasing its Gx Elite vials at booth 36 at the PDA in Rome on February 27 and 28.
Senior vice-president of Europe & Asia Tubular Glass at Gerresheimer Jens Heymann said: “It is absolutely crucial for drugs to be packaged properly in order to ensure drug stability. The exceptional quality of our Gx Elite vials makes them the ideal container for parenteral drugs.”
The highly shatter-resistant vials are extremely durable and free of cosmetic defects. They also boast an incredibly robust structure, while their resistance to delamination protects the drug inside. Simple handling and a range of packaging options ensure that Gx Elite vials can be supplied for end-to-end use on various filling lines. For customers, this means lower costs and higher quality.
Intelligent defect recognition
All of Gerresheimer’s tubular glass plants work with standardized monitoring, inspection, and packaging technologies, which essentially comprise the Gx G3 and Gx RHOC systems.
The inspection systems are developed in-house and form part of a close-knit testing system that ensures the highest precision and quality assurance in line with the latest standards. Complete with five HD cameras, the Gx G3 inspection system makes sure that cosmetic defects are identified reliably, for in-stance. The intelligent software detects and classifies the defects in a few fractions of a second, while the Gx RHOC system ensures dimensional quality with three HD matrix cameras on each side and a hyper-centric ID camera.
Injection vials set the benchmark for primary packaging for parenteral drugs. Gerresheimer’s products come in all sizes and comply with the relevant international standards and pharmacopeias. The company’s range includes solutions for bioengineered drugs and other specialist pharmaceuticals.